- Higher cumulative dosages of isotretinoin were associated with reduced rates of acne relapse and retrial.
- Female patients were more likely to experience relapse but less likely to undergo retrial treatment.
- The study emphasized the need for tailoring daily dosing schedules to individual patient preferences and tolerability, while optimizing cumulative dosage.
- Dermatologist practitioners were associated with increased rates of both relapse and isotretinoin retrial.
- Further research is needed to determine effective prevention strategies for high-risk patients.
Higher Cumulative Isotretinoin Dose Linked to Fewer Acne Relapses
Conexiant
January 15, 2025
